124 related articles for article (PubMed ID: 27841118)
1. Tumour assessment and staging: United Kingdom National Multidisciplinary Guidelines.
Roland N; Porter G; Fish B; Makura Z
J Laryngol Otol; 2016 May; 130(S2):S53-S58. PubMed ID: 27841118
[TBL] [Abstract][Full Text] [Related]
2. Head and neck melanoma (excluding ocular melanoma): United Kingdom National Multidisciplinary Guidelines.
Ahmed OA; Kelly C
J Laryngol Otol; 2016 May; 130(S2):S133-S141. PubMed ID: 27841141
[TBL] [Abstract][Full Text] [Related]
3. Management of thyroid cancer: United Kingdom National Multidisciplinary Guidelines.
Mitchell AL; Gandhi A; Scott-Coombes D; Perros P
J Laryngol Otol; 2016 May; 130(S2):S150-S160. PubMed ID: 27841128
[TBL] [Abstract][Full Text] [Related]
4. Non-melanoma skin cancer: United Kingdom National Multidisciplinary Guidelines.
Newlands C; Currie R; Memon A; Whitaker S; Woolford T
J Laryngol Otol; 2016 May; 130(S2):S125-S132. PubMed ID: 27841126
[TBL] [Abstract][Full Text] [Related]
5. Investigation and management of the unknown primary with metastatic neck disease: United Kingdom National Multidisciplinary Guidelines.
Mackenzie K; Watson M; Jankowska P; Bhide S; Simo R
J Laryngol Otol; 2016 May; 130(S2):S170-S175. PubMed ID: 27841129
[TBL] [Abstract][Full Text] [Related]
6. Imaging in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Lewis-Jones H; Colley S; Gibson D
J Laryngol Otol; 2016 May; 130(S2):S28-S31. PubMed ID: 27841111
[TBL] [Abstract][Full Text] [Related]
7. Management of neck metastases in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Paleri V; Urbano TG; Mehanna H; Repanos C; Lancaster J; Roques T; Patel M; Sen M
J Laryngol Otol; 2016 May; 130(S2):S161-S169. PubMed ID: 27841133
[TBL] [Abstract][Full Text] [Related]
8. Laryngeal cancer: United Kingdom National Multidisciplinary guidelines.
Jones TM; De M; Foran B; Harrington K; Mortimore S
J Laryngol Otol; 2016 May; 130(S2):S75-S82. PubMed ID: 27841116
[TBL] [Abstract][Full Text] [Related]
9. Observing stage-shifts in head and neck squamous cell carcinoma from initial clinical outpatient staging to definite clinical tumour board staging using radiological and endoscopical investigations: will less do?
Braunius WW; van Gils CH; Rosenberg AJ; Hordijk GJ; Moons KG
Clin Otolaryngol; 2011 Aug; 36(4):352-60. PubMed ID: 21635696
[TBL] [Abstract][Full Text] [Related]
10. Pathological aspects of the assessment of head and neck cancers: United Kingdom National Multidisciplinary Guidelines.
Helliwell TR; Giles TE
J Laryngol Otol; 2016 May; 130(S2):S59-S65. PubMed ID: 27841114
[TBL] [Abstract][Full Text] [Related]
11. Imaging in head and neck oncology.
Alberico RA; Husain SH; Sirotkin I
Surg Oncol Clin N Am; 2004 Jan; 13(1):13-35. PubMed ID: 15062359
[TBL] [Abstract][Full Text] [Related]
12. Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines.
Simo R; Robinson M; Lei M; Sibtain A; Hickey S
J Laryngol Otol; 2016 May; 130(S2):S97-S103. PubMed ID: 27841121
[TBL] [Abstract][Full Text] [Related]
13. The role of diffusion-weighted magnetic resonance imaging in the diagnosis, lymph node staging and assessment of treatment response of head and neck cancer.
Payne KF; Haq J; Brown J; Connor S
Int J Oral Maxillofac Surg; 2015 Jan; 44(1):1-7. PubMed ID: 25442741
[TBL] [Abstract][Full Text] [Related]
14. Nutritional management in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Talwar B; Donnelly R; Skelly R; Donaldson M
J Laryngol Otol; 2016 May; 130(S2):S32-S40. PubMed ID: 27841109
[TBL] [Abstract][Full Text] [Related]
15. New TNM staging criteria for head and neck tumors.
O'Sullivan B; Shah J
Semin Surg Oncol; 2003; 21(1):30-42. PubMed ID: 12923914
[TBL] [Abstract][Full Text] [Related]
16. 3D model-based documentation with the Tumor Therapy Manager (TTM) improves TNM staging of head and neck tumor patients.
Pankau T; Wichmann G; Neumuth T; Preim B; Dietz A; Stumpp P; Boehm A
Int J Comput Assist Radiol Surg; 2015 Oct; 10(10):1617-24. PubMed ID: 25477278
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
18. Comparing staging by positron emission tomography with contrast-enhanced computed tomography and by pathology in head and neck squamous cell carcinoma.
Qualliotine JR; Mydlarz WK; Chan JY; Zhou X; Wang H; Agrawal N
J Laryngol Otol; 2015 Dec; 129(12):1213-9. PubMed ID: 26490394
[TBL] [Abstract][Full Text] [Related]
19. Pre-treatment clinical assessment in head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Robson A; Sturman J; Williamson P; Conboy P; Penney S; Wood H
J Laryngol Otol; 2016 May; 130(S2):S13-S22. PubMed ID: 27841110
[TBL] [Abstract][Full Text] [Related]
20. Positron emission tomography (PET) in the staging of head neck cancer: comparison between PET and CT.
Bruschini P; Giorgetti A; Bruschini L; Nacci A; Volterrani D; Cosottini M; Ursino F; Mariani G; Fattori B
Acta Otorhinolaryngol Ital; 2003 Dec; 23(6):446-53. PubMed ID: 15198047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
